Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States

• Principais autores: Nicola P. Klein (Autor), Remon Abu-Elyazeed (Autor), Brigitte Cheuvart (Autor), Winnie Janssens (Autor), Narcisa Mesaros (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliomyelitis and Haemophilus influenzae type b vaccine (DTaP-HBV-IPV/Hib) can further reduce the number of injections in pediatric immunization schedules of countries currently using pentavalent DTaP combination vacc...